Paxman AB (publ) (PAX.ST)

SEK 65.0

(0.0%)

Market Cap (In SEK)

1.23 Billion

Revenue (In SEK)

210.11 Million

Net Income (In SEK)

8.33 Million

Avg. Volume

19.07 Thousand

Currency
SEK
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
31.5-75.8
PE
-
EPS
-
Beta Value
0.802
ISIN
SE0009806284
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Mr. Richard Paxman O.B.E.
Employee Count
-
Website
https://paxmanscalpcooling.com
Ipo Date
2017-06-12
Details
Paxman AB (publ), together with its subsidiaries, develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment in Europe, the United States, Mexico, Japan, Oceania, rest of Asia, and South and Central America. It serves various cancer centers and hospitals. The comapny has a research collaboration agreement with National University Hospital, Singapore for the development of portable cooling and compression device. Paxman AB (publ) was founded in 1996 and is based in Karlshamn, Sweden.

More Stocks